A 36-year-old man with testicular cancer had an acute myocardial infarction during the first course of chemotherapy with bleomycin, etoposide and cisplatin. Since the patient had no significant risk factors for coronary heart disease, the infarction was likely to be attributable to the chemotherapy regimen. The physiopathological mechanisms of this causal relationship are discussed here.
BaguleyB.C., HoldawayK.M., ThomsenL.L., ZhuangL., ZwiL.J.: Inhibition of growth of colon 38 adenocarcinoma by-vinblastine and colchicine: evidence for a vascular mechanism.Eur. J. Cancer, 27: 482–487, 1991.
3.
BissettD., KayeS.B.: Myocardial infarction after chemotherapy for testicular teratoma.Ann. Oncol.,4: 432, 1993.
4.
BoslG.J., LeitnerS.P., AtlasS.A., SealeyJ.E., PreibiszJ.J., ScheinerE.: Increased plasma renin and aldosterone in patients treated with cisplatin-based combination chemotherapy for metastatic germ-cell tumors.J. Clin. Oncol., 4: 1684–1689, 1986.
5.
BurkhardtA., HoltjeW.J., GebbensJ.O.: Vascular lesions following perfusion with bleomycin.Electron microscopic observations. Virchow Arch. A. Pathol. Anat. Histol., 372: 227–236, 1976.
6.
CaronF., ValyY., MeuriceJ.C., PeraultM.C., PatteF.: Myocardial infarction during a treatment combining etoposide and cisplatin (in French).Presse Med.,26: 1674, 1997.
7.
GerlA.: Vascular toxicity associated with chemotherapy for testicular cancer.Anti-Cancer Drugs, 5: 607–614, 1994.
8.
HannunY., VugrinD.: Long-term survival in patients treated for testicular seminoma.J. Surg. Oncol., 43: 177–180, 1990.
9.
HartmannJ.T., KanzL., BokemeyerC.: Diagnosis and treatment of patients with testicular germ cell cancer.Drugs, 58: 257–281, 1999.
10.
IcliF., KaraoguzH., DincolD., DemirkazikA., GunelN., KaraoguzR., UnerA.: Severe vascular toxicity associated with cisplatin-based chemotherapy.Cancer, 72: 587–593, 1993.
NicholsC.R., RothB.J., WilliamsS.D., GillI., MuggiaF.M., StableinD.M., WeissR.B., EinhornL.H.: No evidence of acute cardiovascular complications of chemotherapy for testicular cancer: an analysis of the Cancer Testicular Intergroup Study.J. Clin. Oncol., 10: 760–765, 1992.
13.
PogrebniakH.W., MatthewsW., PassH.I.: Chemotherapy amplifies production of tumor necrosis factor.Surgery, 110: 231–237, 1991.
14.
SchwarzerS., EberB., GreinixH., LindP.: Non-Q-wave myocardial infarction associated with bleomycin and etoposide chemotherapy.Eur. Heart J., 12: 748–750, 1991.
15.
StefanelliT., KuzmitsR., UlrichW., GlogarD.: Acute vascular toxicity after combination chemotherapy with cisplatin, vinblastine, and bleomycin for testicular cancer.Eur. Heart J., 9: 552–556, 1988.
16.
StoterG., KoopmanA., VendrikC.P., StruyvenbergA., SleyferD.T., WillemseP.H., Schraffordt KoopsH., van OosteromA.T., ten Bokkel HuininkW.W., PinedoH.M.: Ten-year survival and late sequelae in testicular cancer patients treated with cisplatin, vinblastine, and bleomycin.J. Clin. Oncol., 7: 1099–1104, 1989.
